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SUMMARY.-Ehrlich ascites cells oranother strainderivedfrom a spontaneous
mouse mammary carcinoma (DiVita's ascites cells) were incubated in vitro
at 370 C. at cell concentrations of 1-2 x 107 cells/ml. with 10-4 M Synkavit in
Spinner-medium under various conditions. The cells were then inoculated
under standard conditions into mice, and the growth of ascites tumour was
determined.
Onthisbasis, Synkavithasbeenshowntoretardthegrowth ofascites tumour
provided that the cells were incubated in vitro at pH 7.4 for 30 minutes. This
retardation of tumour growth was not dependent on the presence of glucose
in the incubation medium and could be observed in the presence of about 5%
ascitic fluid. However, the retardation appearedtobeconsiderablylessmarked
(though readily detectable) when the incubation with Synkavit was performed
anaerobically.
The retardation of tumour growth by Synkavit was abolished completely by
simultaneous incubation with excess ATP or partially by equimolar ATP.
Simultaneous incubation with excess ADP also abolished the retardation by
Synkavit of the growth of tumour. Moreover, ATP addition to the medium
at a later period appeared to be partially successful in abolishing the Synkavit
effect on tumour growth.
The mechanism by which ATP reduced the growth-inhibitory effect of
Synkavit has been partially clarified by investigating the effect of ATP on the
incorporation of a tritiated derivative of Synkavit, TRK 219. The results show
that in Ehrlich ascites cells, simultaneous incubation in Spinner-medium with
excess, or equimolar, ATP reduced the incorporation of labelled metabolites
of Synkavit by 78% or 14% respectively. On the other hand, in a continuous
cell line of human epithelial cells (HEp/2), excess ATP reduced the incorpora-
tion of metabolites of labelled Synkavit very slightly.
These results have been discussed in the light of other evidence to consider
the mechanismwherebyATPreduced the growth-inhibitory effectsof Synkavit.
IN aprevious communication (Harrison, 1968a) it was shownthat under certain
conditions Synkavit (2-methyl-1,4-naphthaquinol bis disodium phosphate)
reduced the incorporation of labelled nucleosides into the RNA and DNA of
Ehrlich ascites tumour (EAT) cells in vitro by virtue ofits inhibitory effect on the
synthesis of ATP and other nucleoside triphosphates. In view of this fact and
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the finding by Friedmann that ATP alleviated the mitotic inhibition induced by
certain quinones (seeMitchell, 1951), it seemed worthwhile to investigate whether
ATP would interfere with the action of Synkavit.
A convenient and reliable test of the growth of ascites tumour cells has been
developed by Rossi and DiVita (1960). Pilot experiments using this technique
and reported previously in a preliminary manner (Harrison, 1968a) appeared to
indicate that viability was not affected significantly when ascites cells were
incubated in vitro with Synkavit. However, subsequent work (Harrison, 1968b)
has shown that this preliminary conclusion was misleading. The present commu-
nication describes the results of many experiments designed to elucidate the
optimum conditions under which treatment with Synkavit in vitro retards the
growth of ascites tumour after subsequent inoculation of ascites cells intraperi-
toneally into mice, and to discover whether ATP or ADP can abolish this growth-
inhibitory effect.
METHODS
Materials
Synkavit, Spinner and imidazole-media were obtained as described previously
(Harrison, 1968a, b). ATP, ADP and other nucleoside derivatives were obtained
from the Sigma Chemical Company. TRK 219 (batches 128-132) was obtained
from the Radiochemical Centre, Amersham.
Incubationconditions
The details of the growth of EAT cells and their use have been described
previously (Harrison, 1968a). DiVita's strain of ascites cells (DV cells), which
was derived originally from a spontaneous mammary carcinoma of the mouse,
was introduced into this laboratory by Dr. G. DiVita, and has been grown by
routine transplantation over a period ofeight years. In all experiments, including
the routine transplantations, Tuck's T.T. albino mice (not inbred) were used.
As a matter of routine practice, the cells were removed from donor mice,
incubated, and inoculated into recipient mice in as short a time as was consistent
with the purpose of the experiment. Since Warburg (1956) has shown that cells
do not survive prolonged incubation in medium containing neither glucose nor
oxygen, the ascites cells were normally incubated in an atmosphere of air at a
concentration of 1-2 x 107 cells/ml. in Spinner-medium containing 1 g./litre
glucose. Under these conditions it was most essential to adjust the pH ofthe
medium with dilute (about N/II) NaOH at least every 5-10 minutes, in order to
keep the pH at the required value to within 0.1 pH unit. In the case of those
experiments performed inthe absence ofglucose, thisprocedure was not necessary.
An alternative procedure would have been to incubate the cells at low concentra-
tion, followed by centrifugation and resuspension at 1-2 x 107 cells/ml. as is
necessary for inoculation. However, this procedure was not adopted since it
would have involved further manipulations after the experiment had begun with
possible damage to the cells and uncertainties in timing. Normally, groups of
10 mice were used; and the various groups of mice were inoculated in such an
order as to minimise systematic errors in the total incubation time. Furthermore,
the pH of the cell suspensions was adjusted as necessary during the period when
the mice were being inoculated.
808INHIBITION BY ATP OF EFFECT OF SYNKAVIT
Growth oftumour
The test used to determine growth ofascites tumour was that devised by Rossi
and DiVita (1960) (see DiVita and Marrian, 1969): namely, the time of tumour
growth was taken to be the time in days after inoculation when the daily body
weight ofthe mouse had increased by 4-5 g. in theprevious 72 hours and continued
to increase on the following day. In a very few cases, some of the mice died or
were killed with obvious growth of tumour although the given test had not been
satisfied; such cases are noted under RESULTS.
Incubation with TBK 219
EAT cells were incubated as described above. HEp/2 cells were grown by Dr.
Dendyasmonolayers inEagle's minimal-essential mediumsupplementedwith 10%
foetal calfserum (FlowLaboratories). HEp/2 cells wererinsedtwicewithSpinner-
medium or bicarbonate-buffered saline at 370 C. before incubating with TRK 219
in the same salt solution used for rinsing the cells. Then the cells were washed
with the appropriate salt solution at 00 C. and removed from the glass by scraping
at 00 C.
Both EAT and HEp/s cells were fractionated into acid-soluble and acid-
insoluble components as described previously (Harrison, 1968a), except that the
freezing and thawing procedure was omitted. The acid-insoluble precipitate
was dissolved in 0-3 NKOH or 1 MNaOH. Samples were normally counted
using the method described by Gill (1967). However, identical results were
obtained by counting small aliquots in toluene scintillator (0.04% BBOT)
containing 30% Triton X-100 (B.D.H.).
RESULTS
Theparameters oftumour growth
Intheir originalmethod Rossi andDiVita (1960) usedDVcells; therefore, itwas
considered necessary to establish whether their method was equally applicable
to EAT cells. The results obtained during the course of various experiments
relatingthetime ofgrowthtothe number ofcellsinoculated arepresentedinFig. 1.
Fromthis curve, some estimate canbe made oftheeffect ofan agent onthegrowth-
potential of the cells. For example, a growth-time of 8x5 days for an inoculum
of2*5 x 10-2 ml. treatedcellsisthe sameasthatforaninoculumof025 X 10-2ml.
untreated cells; this may be interpreted as a 10% survival rate or in terms or an
equivalent delay in the rate ofgrowth ofviable, but damaged cells. It is evident,
therefore, that the method detects only relatively large effects of an agent on the
growth of the cells. Furthermore, there was a lower limit to the size of the
inoculum (ofabout 5 x 10-5 ml. packed cell, i.e. about 2 x 104 cells) below which
tumour did not grow within 30 days after incubation of the cells in Spinner-
medium for 40 minutes. Therefore over the range of inocula normally used,
the method cannot distinguish effects greater than the equivalent of a 99-9%
"kill ". In the present experiments the standard inoculum was chosen to give
maximum sensitivity, i.e. 2*5 x 10-2 ml. packed cells (about 107 cells), though
for some experiments twice this amount was used.
Growth-inhibition bySynkavit
In the present exrperiments, it was found consistently that a 3040 minute
incubation of EAT or DV pells (suspended in Spinner-medium at pH 7*3-7 5
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FIG. 1.-Calibration curve for growth of tumour in relation to the size of inoculum (always in
0.5 ml. Spinner-medium). For reference, 1 ml. packed cells is equivalent to about 4 x 108
cells. The figures in brackets denote the number of separate experiments from which the
individual points have been calculated. - denotes the standard deviation of the mean
value.
TABLE L.-Effect of Various Factors on the Growth-Inhibitory
Incubation conditions
Effect of Synkavit
Cell
1 g./l. conc.
Tumour glucose X 10-7
A EAT - 2
DV
B DV
Time
(minutes)
40
Gas
phase
N2
- 2 40 N2
- 2 35 N2
Air
EAT - 2 35 N2
C EAT + 2 40 Air
Treatment
10-4MSnai
1-MSynikavit
10-4 M Synkavit
10-4M Synkavit
10-4M Synkavit
10-4 M Snai
10-4 M Synkavit
+ 1 40 Air
10-4 M Synkavit
a) Iqo Air Ai JJ1.J r d v * I
11 x 10-4 MSynkavit
1-1 x 10-4MSynkavit + 5%
ascitic fluid
E EAT + 2 45 Air Control, gentle spin
10-4 M Synkavit, gentle spin
Control, fast spin
10-4 M Synkavit, fast spin
Mean time
for growth
5-3+0-2
7-2+0-5
7-3+0-4
8-6+0-4
6-8+0-4
7.9+0J45
5-6±0-2
>29
7.54 9055
12-5+0-75
6-1±0 3
>29
5-6±0-2
>27
4-3±0-1
>30
>30
5-3±0-15
>30
5-1+0-1
>30
No. of mice
tumour grown
10/10
10/10
10/10
10/10
10/10
9/10
10/10
1/10
10/10
10/10
15/15
2/16
11/16
3/16
20/20
0/20
0/20
10/10
0/10
10/10
0/10
No mice grew obvious tumour without satisfying DiVita's test, except one mouse in the control group ofC incubated
at 107 cells/ml. In group E, " gentle spin " denoted the fact that the cells were spun out of the ascitic fluid at the
minimal speed ofabout 50 g; " fast spin " denotes a corresponding procedure at 1000 g. In each case 2-5 x 10-2 ml.
packed cells (107 cells) were injected into each mouse. The pH of the medium during incubation was always con-
trolled in the range 7-2-7-4. The mean time for growth is quoted in days + the standard deviation ofthe mean.
Tn 1AT
_ 1
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TABLE II.-Reduction of the Effects ofSynkavit by ATP
Total Time for
time growth
(minutes) Treatment (days)
A . 35 . .. . 4-3±0-1
2 x 10-4MATP . 4-1±0-05
2-3 x 10-3MATP 4-5±0-2
1-7 x 10-4MSynkavit 7-1±0-2
Synkavit + 2 x 10-4mATP 4-9±0-15
Synkavit + 2-3 x 10-3MATP 4-3±0-1
B . 45 . .. . 5-140-1
10-3 MATP 5-5±0*15
10-4 MSynkavit . > 30
ATP + Synkavit 6-3±0-3
C . 40 . .. . 5-1±0-05
5 x 10-5 MATP initially . 4- 7 ±0-2
5 x 10-4MATP initially . 4-7±0-2
5 X 10-5 M Synkavit initially >26
Synkavit + 5 x 10-5 MATP, both initially . 9 -6+0- 3
Synkavit + 5 x 10-4 M ATP, both initially . 5-0±0- 1
Synkavit initially, 5 x 10-4 M ATP after 20 min. 10*0±0*3
D . 30 . .. . 5-0±0-2
1-34 x 10-3mATP initially 5-740-4
10-4 M Synkavit initially >30
10-4 M Synkavit after 20 min. 5-3±0-2
Synkavit initially, ATP initially 5-0±0
Synkavit initially, ATP after 20 min . >30
E . 30 i x M 4-3±0-1
1- x 10-4 M Synkavit initially . >30
Synkavit after 15 min. . 7* 8±1* 5
8-5 x 10-5 M ATP 4-94±0-3
8-5 x 10-4mATP 4-3±0-1
Synkavit + 9 x 1O-5 M ATP > 30
Synkavit + 9 x 10-4 M ATP after 15 min. . > 30
10-3MADP . 4-1±0
Synkavit + ADP 50±0
No. of
mice grown
10/10
10/10
10/10
10/10
10/10
10/10
10/10
10/10
0/10
10/10
10/10
9/10
10/10
4/10
9/10
10/10
10/10
10/10
10/10
0/10
10/10
1.0/10
0/10
20/20
0/20
19/20
10/10
9/10
0/20
0/2)0
10/10
10/10
All incubations were performed with EAT cells incubated under a gaseous phase ofair in Spinner-
medium at pH 7-2-7-4 containing 1 g./l. glucose and a cell concentration of 2 x 107 cells/ml. In A
the amount of packed cells injected per mouse was 4-5 x 10-2 ml., but in B-E 2-5 x 10-2 ml. Other
details as Table I.
under an atmosphere of air) with 10-4 M Synkavit reduced subsequent growth of
ascites tumour after inoculation of ascites cells into mice (Tables I and II, Fig. 2).
These results may be interpreted in terms of the percentage of cells killed on the
basis of Fig. 1, as described previously.
Consequently, a systematic study was made of possible variables which might
affect this phenomenon. Fig. 2 shows that the inhibition by Synkavit of tumour
growth was dependent on the correct pH of the medium during incubation: in
EAT cells, for example, with a 40 minute incubation at pH 7-4 or pH 7-0 (Fig. 2, A)
Synkavit inhibited completely the growth of tumour; whereas at pH 6-7 the effect
was only partial. However, after a 25 minute incubation, complete growth-
inhibitory effect was only observed at pH 7-4. Thus, comparison of Fig. 2A
and 2B suggests that the extent of the growth-inhibitory effect of Synkavit
increased considerably as the incubation time was increased from 25 to 40 minutes.
Furthermore Table IID and E, indicates that with EAT cells the inhibitory effect
was much smaller when incubation with Synkavit at pH 7-3 was restricted to
10-15 minutes. It may be noted that Fig. 2B shows that the pH-dependence
also held true in the case of DV cells, although the effect seemed to be slightly less
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FIG. 2.-Dependence ofthe growth-inhibitory effect ofSynkavit on pH and glucose. A and B
refer to separate experiments when the times ofincubation were 40 and 25 minutes at 370 C.
respectively. Closed symbols refer to untreated cells, open symbols to cells treated with
1-04 x 10-4 M Synkavit. All cells were incubated in Spinner-medium without glucose,
except in the case of the experiment denoted by the circles. EAT cells were used in all
experiments except those denoted by inverted triangles which involved DV cells. Those
tumours which did not grow are counted as growing on the 30th day. p denotes standard
deviation of mean value.
than in the case ofEAT cells. The growth-inhibitory effect ofSynkavit occurred
irrespective of whether glucose was present in the medium or not (Fig. 2A).
This fact eliminates two possibilities: (1) that the Synkavit-effect may have
depended onthepresence ofglucoseinthe medium; and (2) that Synkavitinhibited
tumour-growth by virtue of damage to the tumour-cell membrane incurred by
adjustment ofthe pH ofthe medium (see METHODS, Incubation conditions).
The dependence of the effect of Synkavit on aerobic or anaerobic conditions
during incubation is illustrated in Table IA and B: in both EAT and DV cellsthe
growth oftumour was retarded only slightly when the cells were incubated in the
presence of Synkavit in nitrogen-saturated medium contained in full, sealed
bottles. Therefore, the effect of Synkavit on the growth of tumour depends to
some extent on the presence of oxygen during incubation (for further comment
see DISCUSSION).
The following additional factors which might have affected the growth-
inhibitory effect of Synkavit were eliminated: (a) Synkavit was effective when
EAT cells were incubated both at concentrations of 107 and 2 x 107 cells/ml.
(Table IC); (b) the effect on EAT cells was not abolished by the presence ofabout
5% ascitic fluid in the incubation medium (Table ID); and (c) Synkavit inhibited
the growth of EAT cells which had been obtained by centrifugation at 50 g and
1000 g (Table IE).
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Reduction by ATP and ADP of the growth-inhibitory effect ofSynkavit
Table II, A-D, shows that the growth-inhibitory effect of Synkavit on EAT
cells may be reduced by simultaneous incubation with 10 x excess, or, less
effectively, by equimolar ATP. Consequently, some attempt was made to decide
whether or not ATP acted bypreventing theincorporation ofthe active metabolite
ofSynkavit: Table II, C-E, gives the results ofthree similar experiments in which
excess or equimolar ATP was added either simultaneously or part-way through
the incubation of EAT cells with Synkavit. The results given in Table IIC
show that 10 X excess ATP added half-way through the 40 minute incubation
period with 5 X 10-5 M Synkavit reduced the time for tumour growth in much
the same way as did equimolar ATPwhen addedinitially. However, inthe results
of the experiments presented in Table IID and E, excess ATP added half-way
through the incubation with Synkavit could not reduce the effect of the latter
compound; and in the experiment described in Table IIE equimolar ATP added
initially did not reduce the effect of Synkavit. Therefore, it appears that the
magnitude of the Synkavit in this case was greater than that described in Table
IIC (although in both cases Synkavit prevented growth oftumour within 30 days).
A different approach to the question of how ATP abolishes the growth-
inhibitory effect of Synkavit is to investigate the effect of compounds related to
ATP. Thus 10 x excess ADP abolishes the growth-inhibitory effect of Synkavit
when the two compounds are incubated simultaneously with the tumour cells
(Table IIE).
Effect of ATP on labelling with TRK 219
One explanation of the abolition by ATP of the growth-inhibitory effect of
Synkavit is that ATP prevented the incorporation of the active metabolite of
Synkavit. This possibility may be investigated simply by determining whether
or not simultaneous incubationwith ATPreduces the incorporation ofthe tritiated
form of Synkavit, TRK 219.
When EAT cells were incubated with TRK 219 for 40 minutes, the presence
of 10 x excess ATP throughout the entire incubation time decreased considerably
the incorporation of activity (Table III). However, simultaneous incubation
with equimolar ATP had only a slight effect (Table III). It is important to note
that under these conditions almost all the activity incorporated by the ascites
cells was associated with the acid-insoluble fraction.
The results obtained with HEp/2 cells are given in Table IV. In this case,
simultaneous incubation with 10 x excess ATP had only a small effect on the
incorporation of activity during incubation with TRK 219 for 20 or 40 minutes in
either Spinner-medium or bicarbonate-buffered saline. Furthermore, the incor-
poration ofactivity was approximately the same whenHEp/2 cells were incubated
TABLE III.-Effect of ATP on Incorporation ofTRK 219 by EAT Cells
Acid-soluble Acid-insoluble
% of total activity associated with fraction . 7; 7 . 93; 93
% control activity inpresence ofequimolar ATP . 86; 86 . 87; 86
% control activity inpresence of 10x excess
ATP . . . . . . . . 37;39 . 20;24
EAT cells (107/iml.) were incubated with 10-4 M TRK 219 (62-65 Ci/mM) for 40 minutes in Spinner-
medium, pH 7-4, mirnu8 glucose, in an atmosphere ofair. Values given are for duplicate experiments.
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TABLE IV.-Effect of 10 x Excess ATP on Incorporation ofTRK 219
by HEp/2 Cells
Effect of ATP
Incubation % Total % control value Ratio uptake in Spinner/saline
time activity
(min.) Medium acid-insoluble Acid-soluble Acid-insoluble Acid-soluble Acid-insoluble
20 . Spinner . 45+, 55 87+, 73 63+, 71 . 60+, 94 36+, 86
Saline . 57, 58 . 70, 68 72, 73 . 100 100
40 . Spinner . 26 . 78 80 . 190, 65=, 175 82, 16=, 100
Saline . 45 . 90 110 . 100 100
Cells (about 6-8 x 105/ml. incubation medium) were incubated with 10-4 M TRK 219 (59 Ci/mM)
at pH 7-4. The pH of the bicarbonate-buffered saline was difficult to control as accurately as that of
Spinner-medium.
+: incubated at pH 7*0.
e cell concentration: 3 x 105 cells/m. incubation medium.
with TRK 219 in Spinner-medium or buffered-saline. Only in one particular
experiment, in which the concentration ofHEp/2 cells was lower than usual, was
the incorporation of activity in Spinner-medium less than that in buffered-saline.
Significantly, in the experiments performed with HEp/2 cells, the percentage ofthe
incorporated activity associated with the acid-insoluble fraction was much lower
than in the case of EAT cells. This probably reflects the lower concentration of
HEp/2 cells in these experiments (about 7 x 105/ml., cf. with EAT cells: 107/ml.).
DISCUSSION
It is clear from the present results that in the case of both EAT and DV cells
incubation in vitro with 10-4 M Synkavit retards their growth if subsequently
inoculated into mice, provided that the following conditions are strictly observed:
(a) The pH ofthe medium must be controlled within the range 7-2-7*4;
(b) For maximum effect, the incubation must be performed aerobically;
(c) For maximum effect, the time of incubation should be not less than 30
minutes.
These conditions are critical and are related to those pertaining to the biochemical
effects of Synkavit (Harrison, 1968a). Namely, both biochemical and growth-
inhibitory effects are pH-dependent in much the same manner; and both occur in
the absence ofoxygen, although the growth-inhibitory effect is less severe anaero-
bically. The reason for the latter is not understood, but it is considered unlikely
to be due to a better degree ofanoxia in the present experiments (for a considera-
tion of this point regarding the biochemical experiments, see Harrison 1968a).
The effect of Synkavit on subsequent growth in vivo is not dependent on
incubation in the presence of glucose in vitro. This may be interpreted to mean
that the incorporation of the active metabolite of Synkavit into the cell is not
glucose-dependent; whereas the biochemical effects ofthis incorporated metabolite
are glucose-dependent. This interpretation is supported by the finding by Dr.
Valerie Fisher (personal communication) that the dephosphorylation of Synkavit
invitro is notglucose-dependent. Since theprimarybiochemical effect ofSynkavit
was considered to be the reduction of the synthesis and cellular content of ATP,
it may be reasonably argued that once some metabolite of Synkavit has been
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incorporated into the cells in vitro, it is able to uncouple the energy-yielding
processes whereby the glucose supply in vivo is utilised for tumour growth.
It is pertinent to consider at this pointthe recent report by DiVita and Marrian
(1969). The experimental conditions used by these workers differed from those
used by the present author in only three respects: the lower cell concentration
during incubation, the presence ofascitic fluid in the incubation medium, and the
speed of centrifugation of the cells. Each of these differences in technique has
been shown in the present work not to reduce the growth-inhibitory effect of
Synkavit. Nevertheless, DiVita and Marrian, using groups of 30 mice, were not
able to detect any effect of Synkavit on the growth of DV cells when incubated
under anaerobic conditions for 30 minutes and at concentrations of 10-4M or
10-2 M in Spinner-medium containing 1 g./litre glucose or physiological saline at
an initialpH of 7*0-7*5. Thus, on the basis ofthe present work, it is evident that
DiVita and Marrian did not realise, in their choice of anaerobic conditions and
wider pH range, the optimum conditions for the growth-inhibitory effect of
Synkavit. Moreover, care mustbetakeninjudgingthesignificanceofexperiments
performed with high concentrations of Synkavit: Dendy (1969) has evidence to
show that in those types of cells which show a selective uptake of the drug (to
which both DV and EAT cells appear to belong-see Dendy, 1970), at concentra-
tions higher than 3-15 X 10-4 M the uptake of a tritiated derivative of Synkavit
(TRK 219) falls in absolute terms as the molarity is increased. In fact, Dr.
D. H. Marrian (personal communication) has recently observed a large inhibition
of tumour growth by 10-4 M Synkavit when EAT cells were incubated in air for
40 minutes in Spinner-medium minus glucose, and maintained at pH 7 3-7 4.
Finally in this context, it may be noted that Dendy (1970) has evidence that
those types of cells which show a selective uptake of tritiated Synkavit are selec-
tively killed, as judged by cloning experiments.
Effect of ATP
The simplest interpretation of the fact that ATP may reduce the growth-
inhibitory effect of Synkavit would be that it reduced the incorporation of the
active metabolite of Synkavit. This may be envisaged as competition between
ATP and Synkavit at the enzymic dephosphorylation sites which are thought to
be involved in the conversion of Synkavit to its active metabolites. For the
sake of clarity, the experiments concerning 10 x excess or equimolar ATP will be
discussed separately.
(i) 10 x excess ATP.-From the experiments described previously, it is clear
that incubation of EAT cells with TRK 219 plus 10 x excess ATP reduces the
incorporation of activity by about 80%. This may be compared with a complete
reduction in the growth-inhibitory effect of Synkavit when incubated simul-
taneously with 10 x excess ATP. Thus, the simple competition hypothesis
would explain these results adequately. The results obtained when 10 x excess
ATP was added half-way through the incubation with Synkavit do not permit
definite conclusions to be drawn. Nevertheless, these results are not inconsistent
with the competition hypothesis. Moreover, the experiment involving 10 x
excess ADP would be readily explained if it is assumed that ADP could saturate
the dephosphorylation sites in a similar manner to ATP.
The results presented for HEp/2 cells are not relevant to the growth-inhibitory
effect of Synkavit. Nevertheless, they do show clearly that 10 x excess ATP
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inhibits only slightly the incorporation of activity from TRK 219 by these cells,
either when incubated in Spinner-medium or bicarbonate- buffered saline. Thus,
simple competition between ATP and Synkavit is not necessarily observed in cells
which show a selective uptake ofTRK 219 (Dendy, 1970).
(ii) Equimolar ATP.-Simultaneous incubation withequimolar ATP was shown
to reduce the incorporation of activity from TRK 219 into EAT cells by 14%.
The corresponding reduction in the growth-inhibitory effect ofSynkavit was more
variable. However, on the basis of Fig. 1, the reduction can be estimated to be
about 15-40%, in terms ofthe number ofcells killed orretarded in growth. Thus,
in view of the errors involved in these comparisons, these results do not disprove
the simple competition hypothesis.
However, certain other observations (Fisher, personal communication) must
be considered in this context. Her studies of the rates of dephosphorylation of
mixtures ofATP and Synkavit by EAT cells suspended in phosphate-free medium
(containing the same metal ions as Spinner-medium, but buffered with imidazole)
led her to believe that ATP stimulated the dephosphorylation of Synkavit. The
same author showed that imidazole did not affect the dephosphorylation of
Synkavit, and deduced from the different pH-dependences and responses to
inhibitors that the enzymic sites for dephosphorylation of Synkavit and ATP
were probably not identical. Consideration of these results in relation to those
described in the present studies may suggest that in EAT cells inorganic phosphate
may play some intermediate role in controlling competition between dephosphory-
lation ofSynkavit andATP, possibly at different enzymatic sites. Unfortunately,
the results obtained by Dendy (1970) on the uptake of TRK 219 in Spinner-
medium and phosphate-free medium do not permit any conclusion on this point.
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